0 Comment

La cabergolina se sugiere actualmente en lugar de bromocriptina, debido a su del período menstrual debe suspenderse el fármaco y confirmar el embarazo. Publisher: Cabergolina y bromocriptina son los fármacos más utilizados probablemente aumenta la probabilidad de embarazo, y se asocia a. El uso de cabergolina no afecta el resultado de embarazo (tasa de embarazo clínico, tasa de aborto espontáneo), ni existe un aumento en el riesgo de eventos .

Author: Grozragore Brarr
Country: Andorra
Language: English (Spanish)
Genre: Spiritual
Published (Last): 21 September 2014
Pages: 500
PDF File Size: 11.2 Mb
ePub File Size: 20.74 Mb
ISBN: 163-7-81386-959-4
Downloads: 19164
Price: Free* [*Free Regsitration Required]
Uploader: Zulujar

Primary medical therapy of micro- and macroprolactinomas in men. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. In microprolactinomas the ophthalmologic examination is no formal indication. In the absence of menstrual period, the drug should be discontinued and confirm pregnancy. Indian J Med Cabergoljna. There is evidence that breastfeeding no increased risk for tumor vabergolina. Both, bromocriptine and cabergoline, showed no evidence of obstetric and neonatal complications; however, experience with bromocriptine is higher.

[Update on endocrinology: management of prolactinomas during pregnancy].

Comparison of the effects of cabergoline and bromocriptine in women with hyperprolactinemic amenorrhea. Cabergoline currently suggested rather than bromocriptine due to their excellent tolerability and long half-life.

Resistance to cabergoline as compared with bromocriptine in vabergolina Diagnosis and treatment of yperprolactinemia: Cabergoline and bromocriptine are among the most commonly used drugs to treat prolactinoma.


The hyperprolactinemia is associated with anovulation and infertility. If growth in the adenoma is suspected, nuclear magnetic resonance and neuro-ophthalmologic examination should be performed. Cabergolina versus bromocriptina para la hiperprolactinemia o prolactinoma.

Middle East Fertility Society Journal. Su principal desarrollo es la base de datos Epistemonikos www. La cabergolina se sugiere actualmente en lugar de bromocriptina, debido a su excelente tolerabilidad y prolongada vida media.

Cabergolina y embarazo semanas

Cabergoline Comparative Study Group. Medwave se preocupa por su privacidad y la seguridad de sus datos personales.

Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: The patients with macroprolactinomas should be monitored clinically and evaluate the symptoms related to increased tumor size. Todos los estudios compararon bromocriptina versus cabergolina.

It is not clear whether cabergoline is also more effective with respect to tumor growth because the certainty of the evidence is very low. Caebrgolina is a long-acting dopamine receptor agonist which might offer advantages over bromocriptine.

The prolactinomas are the most common functioning pituitary tumors. Comparative effects of bromocriptine and cabergoline on serum prolactin levels, liver and kidney function tests in hyperprolactinemic women. However, it is not clear if this translates into clinical benefits. Para un estudio no se especifican dosis de cabergolina y bromocriptina en ninguna de las revisiones identificadas [11].

In general, it is recommended that fetal exposure to all drugs be limited to as short a period as possible. Hay evidencia de que la lactancia materna no presenta mayor riesgo para el crecimiento tumoral. Pakistan Journal of Medical Sciences Online. La bromocriptina se asocia a mayores efectos adversos que cabergolina.



Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients. Results of a national multicenter randomized double-blind study]. Sobre los desenlaces incluidos en este resumen. Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males.

De los estudios no aleatorizados incluidos, los tres corresponden a cohortes retrospectivas. Comparison of cabergoline and bromocriptine in t with asymptomatic incidental hyperprolactinemia undergoing ICSI-ET. Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified two systematic reviews including 12 studies addressing the question of this article, including five randomized controlled trials.

J Clin Endocrinol Metab. N Engl J Med. Cabergoline or bromocriptine for prolactinoma?.

Osteocalcin levels in patients with microprolactinoma before and during medical treatment. Por lo tanto, parte de la evidencia incluida en este resumen no fue considerada.